Relaxin does not improve Angiotensin II-induced target-organ damage.
Relaxin is a corpus-luteum produced protein hormone with vasodilatatory, anti-fibrotic, and angiogenic properties that are opposite to angiotensin (Ang) II. We investigated whether or not relaxin ameliorates Ang II-induced target-organ damage. We used double transgenic rats harboring both human reni...
Saved in:
| Main Authors: | Nadine Haase, Julianna Rugor, Lukasz Przybyl, Fatimunnisa Qadri, Dominik N Müller, Ralf Dechend |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0093743&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-acting relaxin analogues: a novel tool in cardiology
by: Łukasz Wołowiec, et al.
Published: (2025-08-01) -
Relaxin protects astrocytes from hypoxia in vitro.
by: Jordan M Willcox, et al.
Published: (2014-01-01) -
Inhibition of angiotensin Ⅱ type 1 receptor on Renal Fibrosis and Podocyte Damage in Angiotensin Ⅱ-induced Hypertensive Nephropathy
by: Zhang He-ping, et al.
Published: (2022-04-01) -
Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II
by: Agostino Virdis, et al.
Published: (2011-01-01) -
Mediation Effect of Relaxin in Cerebrospinal Fluid on the Association Between Smoking and Sleep
by: Xu Z, et al.
Published: (2025-04-01)